NDC 0591-2533
Dalfampridine
Dalfampridine
Dalfampridine is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Dalfampridine.
| Product ID | 0591-2533_f2d33c82-a69f-4f6a-bd74-2c91efd6cab8 |
| NDC | 0591-2533 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dalfampridine |
| Generic Name | Dalfampridine |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-05-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA206836 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | DALFAMPRIDINE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |